Esophageal Cancer Treatment
Orange Regional Medical Center provides the latest in diagnostic tools to identify and manage conditions related to the digestive tract.
Diagnositic Testing for Esophageal Cancer
Endoscopic Ultrasound (EUS) is the most common diagnostic procedure for esophageal cancer performed at Orange Regional Medical Center. This procedure combines ultrasound technology with endoscopy and has become an integral part of the management of a variety of gastrointestinal conditions.
The procedure is similar to an upper endoscopy exam, but the scope is additionally equipped with ultrasound technology to help assess tissues below the surface of the esophagus. The ultrasound component uses sound waves to create a picture of the inside of the body and is used to assess possible tumors of the esophagus, stomach, pancreas, gall bladder and liver, and chest cavity tumors. It is also used to evaluate abdominal pain and diseases of the pancreas, such as pancreatitis, and gallbladder, like gallstones and bile duct obstructions.
The combined medical techniques enhance the physician’s ability to accurately stage gastrointestinal tumors and lung cancers up to 90% and help the patient plan treatment options.
About Esophageal Cancer
Esophageal cancer starts in the inner layer (the mucosa) and grows outward (through the submucosa and the muscle layer). There are two main types of esophageal cancer:
Squamous Cell Carcinoma
The surface of the esophagus is normally lined very flat, thin cells called squamous cells. Cancer starting in these cells is called squamous cell carcinoma. This type of cancer that can occur anywhere along the esophagus, but most often occurs in the middle of the esophagus. According to the American Cancer Society, squamous cell carcinoma was once the most prevelant type of esophageal cancer in the U.S. - now it makes up less than half of esophageal cancers.
Cancers that start in mucus-secreting glands in the esophagus are called adenocarcinomas. Adenocarcinoma most often occurs in the lower portion of the esophagus, where the esophagus joins the stomach. This is due to the fact that this type of cell is not normally part of the inner lining of the esophagus. Before an adenocarcinoma can develop, gland cells must replace an area of squamous cells, which is what happens in Barrett’s esophagus.
Esophageal cancer makes up about 1% of all cancers diagnosed in the United States.
The American Cancer Society’s estimates for esophageal cancer in the United States for 2017 are:
- About 16,940 new esophageal cancer cases diagnosed (13,360 in men and 3,580 in women)
- About 15,690 deaths from esophageal cancer (12,720 in men and 2,970 in women)
About Barrett's Esophagus
Barrett’s esophagus is a pre-cancerous condition affecting the lining of the esophagus: the swallowing tube that carries foods and liquids from the mouth to the stomach. Barrett’s esophagus is most often diagnosed in people who have long-term gastroesophageal reflux disease (GERD) — a chronic regurgitation of acid from the stomach into the lower esophagus.
Gastroesophageal reflux disease (GERD) is a disorder in which stomach acid and enzymes cause injury to the esophageal lining, producing symptoms such as heartburn, regurgitation, and chest pain. In some patients with GERD, the normal esophagus cells are damaged. Over time, this damage can result in inflammation and genetic changes that cause the cells to become altered. The tissue takes on a different appearance and microscopically is no longer esophageal tissue, but rather becomes intestinal tissue. This is called “intestinal metaplasia” or Barrett’s esophagus.
Left untreated, it can progress to a dangerous type of esophageal cancer. Orange Regional offers Radio Frequency Ablation to patients to treat Barrett’s Esophagus.
Education and Support
From cancer support groups and screenings to our clinical trials program, we provide comprehensive cancer care. If you or a loved one has cancer, count on Orange Regional’s experienced physicians, compassionate staff and live-saving technologies to fight the battle, together with you.
Our Patient Navigators are specially-trained to help guide and support you and your family through your cancer care treatment and recovery.
We are an active participant in the Rapid Quality Reporting System (RQRS), a data collection and reporting system with near real-time information on cancer patients.
From living with cancer to living beyond it, at Orange Regional, we're proud and committed to offering survivorship services from support groups to rehabilitation.
We're committed to offering the best available survivorship services. This is why we have implemented our comprehensive Cancer Rehabilitation Program.
Cancer Support Groups & Classes
MEET OUR TEAM
- Eileen Schmidt,
Palliative Care Patient Navigator
Eileen Schmidt specializes in providing one-on-one guidance through your palliative care treatment. She also facilitates our Lung Cancer Support Group.
- Arvind G. Kamthan, M.D., M.R.C.P. (U.K.), F.A.C.P.,
Dr. Kamthan completed his medical training at SMS Medical College in India and residency training at Charleston Area Medical Center at West Virginia University with a fellowship at Mt. Sinai Medical Center in New York. Dr. Kamthan has been practicing medicine for over 23 years.
- Cleveland W. Lewis, Jr, MD,
Cleveland W. Lewis, Jr, MD is an Orange Regional Medical Group surgeon specializing in thoracic procedures. Dr. Lewis will also be serving as Assistant Director of the Surgical Residency program. Dr. Lewis received his medical degree and completed his Cardiothoracic Surgery Residency at Duke University School of Medicine, in N.C.
- Nathaniel Margolis,
Medical Director, Breast Center
Nathaniel Margolis, M.D. is medical director of the Ray W. Moody, M.D. Breast Center. His combination of breast disease clinical knowledge and humane, compassionate care makes him the perfect leader for our nationally-recognized breast care program.
- Paramjeet Singh,
Medical Director, Surgical Oncology / General Surgeon
Paramjeet Singh, M.D., FACS is an Orange Regional Medical Group surgeon. He specializes in General Surgery and is Medical Director of Surgical Oncology. He provides patients with hepato-biliary surgical, trauma surgery surgical oncology services, as well as being a member of the Medical Group’s General Surgery team.
- Betty Koshy,
Manager, Radiation Oncology
- Regina Toomey Bueno,
- Peter Bezdicek,
- Eric Saint Clair,
- Nader Okby,
Tumor Site Development
- Sergey Koyfman,
Head & Neck Tumor
- Thomas Eanelli,
- Adel Abadir,
- Jeffrey Stewart,
Medical Director, Cancer Care Program
- Sara Sargente,
Head & Neck Cancer Patient Navigator
- Jayne O’Malley,
Lung Cancer Nurse Navigator
- Michele Worden,
Breast Cancer Patient Navigator
Count on Michele’s personal and clinical experience to help guide you through the wide range of services and treatments available at the nationally-accredited Ray W. Moody, M.D. Breast Center.